In today’s competitive CDMO landscape, the ability to offer integrated, flexible, and high-quality services across development and manufacturing is more important than ever. At Adragos, our development site in Athens plays a central role in enabling such synergy, acting as a strategic hub that connects innovation, adaptability, and global execution.
Our expertise is not limited to troubleshooting or process optimization; it spans the entire lifecycle of a medicine. Adragos Athens is a pharmaceutical development site. Here, we go beyond generics. We design and develop value-added medicines tailored to our customers’ strategies and market demands, from concept to commercial. This capability positions us as a true partner, not just a service provider, in product development.
Our Integrated Network
One of our strongest assets is the integration between our dedicated development hub in Athens and our network of manufacturing facilities across Europe and Japan. This alignment allows us to transfer projects seamlessly while maintaining full control over quality, timelines, and regulatory compliance.
Having Athens as a base for development and then transferring it to other sites in Europe is a great competitive advantage. We are able to use the expertise from development directly during the most critical phase: from tech transfer to commercial scale.
This end-to-end coordination enhances tech transfer, scalability, and minimizes risks, ensuring our partners can move from lab to market with confidence and speed.
Flexibility is essential in the CDMO space. Often, customers come to us with an existing process that doesn’t fully align with available manufacturing setups. Thanks to early-stage alignment between Athens and our commercial sites, we can anticipate and solve compatibility challenges.
Supporting Multi-Market and Complex Projects
Our network isn’t just European. It’s global, with manufacturing capabilities extending to Japan. This global presence is a unique advantage for companies looking to commercialize across strict regulatory markets.
For example, Japan is known for its rigorous pharmaceutical standards. Through our Kawaoge site, Adragos can serve as a quality, regulatory, and operational gateway into the Japanese market. We help our customers launch in strict markets like Japan using the knowledge and expertise we have locally. That’s a true differentiator.
Additionally, our sites have a legacy of over 300 years combined in pharmaceutical excellence, from development to clinical trial supplies and commercial launches. This extensive expertise allows us to support biotech innovators and established pharma alike, in everything from new chemical entities to global product launches.
A Synergistic Vision
What truly sets Adragos apart is the synergy between development and manufacturing, between European precision and global ambition, and between our customer-first mindset and operational execution. Athens is not just a facility; it’s pharmaceutical innovation, powered by integration, flexibility, and trust.
